For many companies, making headway in a clinical trial is cause for celebration. But today, Immutep Ltd [ASX:IMM] has done it twice! That optimism has seen the IMM share price climb 23.26% higher at time of writing. A tidy return for a company…
My co-worker and fellow editor Lachlan recently covered this wonderful world of medtech. Shareholders of Hydrix Ltd [ASX:HYD] can tell you all about that. Because the company’s 22.64% share price gain today is just the latest win in a recent revival of this long-forgotten stock…
The Sydney-based biotechnology company recently announced a phase 1 trial aimed at new classes of synthetic anti-infectives. At the time of writing the Recce Pharmaceuticals Ltd [ASX:RCE] share price is up 4.40%, to trade at $1.66, on the back of this positive announcement…
The good news keeps on coming for stocks working on COVID-19 treatments. The latest company to confirm some good news is AnteoTech Ltd [ASX:ADO]. A small-cap biotech firm that has been working on a product that tests for COVID-19 symptoms…
The hunt for a COVID-19 vaccine is ramping up. We learnt yesterday that the government has spent $1.7 billion on potential treatments. Hedging their bets on some $84 million worth of doses that will be ready for free rollouts by 2021…
It’s not every day that you see a company enter an intraday trading halt. Especially after starting the day with a massive announcement to send your share price 76.92% higher! That is exactly what Opyl Ltd (ASX:OPL) has done though…
Fat Tail Daily is brought to you by the team at Fat Tail Investment Research
Copyright © 2026 Fat Tail Daily | ACN: 117 765 009 / ABN: 33 117 765 009 / ASFL: 323 988
